OIL optiscan imaging limited

Ann: Optiscan Reveals InForm Imaging Device for Pathology, page-2

  1. 7,472 Posts.
    lightbulb Created with Sketch. 1184
    We now look forward to updating the market on further InForm™ device-specific developments over coming months, including its planned integration with Optiscan’s cloud-based telepathology streaming platform



    The InForm™ is DICOM-compliant and PACS-enabled, allowing the device to be connected to hospital or laboratory archiving systems in a fashion similar to that of radiology platforms such as CT or MRI. This is a unique and intentional feature for a pathology device, and is a key enabler for seamless adoption and integration of digital pathology into the wider healthcare space, one that has lagged behind diagnostic radiology by decades. Additionally, the device is designed to integrate with Optiscan’s cloud-based telepathology streaming platform, which allows remote consultation in real time anywhere in the world, and which is expected to be revealed in mid-2025.
    Last edited by dory: 19/02/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
12.5¢
Change
-0.010(7.41%)
Mkt cap ! $104.4M
Open High Low Value Volume
14.0¢ 14.0¢ 12.5¢ $13.58K 98.36K

Buyers (Bids)

No. Vol. Price($)
4 100857 12.5¢
 

Sellers (Offers)

Price($) Vol. No.
14.0¢ 98116 4
View Market Depth
Last trade - 15.30pm 13/06/2025 (20 minute delay) ?
OIL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.